Additional file 2 of Efficacy and tolerability of the investigational topical cream SD-101 (6% allantoin) in patients with epidermolysis bullosa: a phase 3, randomized, double-blind, vehicle-controlled trial (ESSENCE study)
dataset
posted on 2020-06-24, 03:36 authored by Amy S. Paller, John Browning, Milos Nikolic, Christine Bodemer, Dedee F. Murrell, Willistine Lenon, Eva Krusinska, Allen Reha, Hjalmar Lagast, Jay A. BarthAdditional file 2:. ESSENCE study site information. Presents study investigators, country, and patient numbers for all study sites.
